Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home Setting

NCT02546869 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02546869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02546869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home Setting
Lead sponsor
Hoffmann-La Roche
Phase
Phase 3
Overall status
Withdrawn
Start date
September 29, 2015
Completion date
June 29, 2016
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma